MAY 27, 2016 8:22 AM PDT

Immunotherapy Drug Helpful in Melanoma

Most people have heard of the drug Keytruda, used most notably by former President Jimmy Carter for his advanced melanoma, but the details were not specific. A new report out this month is showing just how powerful the drug can be in treating deadly late stage melanomas. In 2011, the median survival of patients with melanoma was less than one year. The new study on Keytruda shows that 40% of melanoma patients treated with it were still alive three years later, an astounding increase in survival rates.

The drug is expensive, but since it is FDA approved and not experimental, it is covered by insurance in most cases. Researchers at Dana Farber, where the drug is being studied, caution that it's far from a cure, but they are hopeful that the drug's ability to stimulate the immune system to target and kill cancer will be the future of treating melanoma and hopefully other forms of cancer as well.
About the Author
Bachelor's (BA/BS/Other)
I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
Loading Comments...
  • See More